ONCLIVE NEWS NETWORK: ON LOCATION WILL BE LIVE AT ESMO THIS WEEK - STAY TUNED FOR MORE INFORMATION!

Dr. Rotkowitz Defines Personalized Medicine

Michael Rotkowitz, MD
Published: Monday, Jul 23, 2012

Michael Rotkowitz, MD, medical oncologist, Cancer Treatment Centers of America, Eastern Regional Medical Center, explains that the movement towards the use of targeted therapies and personalized medicine has resulted in the use of genetic markers and gene expression to help determine the best therapy.

However, Rotkowitz does not believe the personalization of medicine should stop at targeted therapy. He stresses that to truly personalize care each patient should be treated as an individual and not just a number in a trial. Not only should their genetics be considered but also their nutritional and physical well-being, which may require supplements, physical, or occupational therapy.

This type of mind-body approach allows the patient to get the most out of their therapy. Giving a targeted therapy to a patient who has a strong support system and a strong quality of life results in a better outcome.

Michael Rotkowitz, MD, medical oncologist, Cancer Treatment Centers of America, Eastern Regional Medical Center, explains that the movement towards the use of targeted therapies and personalized medicine has resulted in the use of genetic markers and gene expression to help determine the best therapy.

However, Rotkowitz does not believe the personalization of medicine should stop at targeted therapy. He stresses that to truly personalize care each patient should be treated as an individual and not just a number in a trial. Not only should their genetics be considered but also their nutritional and physical well-being, which may require supplements, physical, or occupational therapy.

This type of mind-body approach allows the patient to get the most out of their therapy. Giving a targeted therapy to a patient who has a strong support system and a strong quality of life results in a better outcome.


View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Clinical Interchange™: Translating Research to Inform Changing Paradigms: Assessment of Emerging Immuno-Oncology Strategies and Combinations across Lung, Head and Neck, and Bladder CancersOct 31, 20182.0
35th Annual Chemotherapy Foundation Symposium: Innovative Cancer Therapy for Tomorrow® Clinical Vignette SeriesJan 31, 20192.0
Publication Bottom Border
Border Publication
x